We listed several of the most frequently altered genes in the data set, and the frequency of IDH1 gene mutations was high in PRAD patients Figure 1(f)), while the survival rate of patients with IDH1 mutations was low. The gene discussed is IDH1; the disease is prostate adenocarcinoma.